Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Plus Lazertinib Outperforms Osimertinib in EGFR-Mutated NSCLC Nov 29, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Nivolumab Plus Chemo Shows Promising EFS in Resectable Lung Cancer Nov 29, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Digital vs. Manual PD-L1 Tumour Cell Scoring: A Comparison Nov 29, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Subtypes & Outcomes in IMpower 150 Study Nov 29, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Immune Biomarkers and Survival in Stage III NSCLC: Analysis from NRG-RTOG 0617 Nov 28, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Repotrectinib Efficacy in ROS1+ NSCLC: Update from TRIDENT-1 Trial Nov 27, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Savolitinib for First-Line MET Exon 14 NSCLC Nov 27, 2023
Colorectal Cancer,Gastrointestinal Cancer,Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) ABBV-400 Shows Promise in Early Human Trials for Solid Tumors Nov 21, 2023